Article
Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Protein engineering, design & selection : PEDS - 1 Mar 2009
Schlapschy Martin, Fogarasi Marton, Gruber Helga, Gresch Oliver, Schäfer Claudia, Aguib Yasmine, Skerra Arne
Abstract excerpt
An alphaCD30xalphaCD16 bispecific monoclonal antibody (MAb) was previously shown to induce remission of Hodgkin's disease refractory to chemo- and radiotherapy through specific activation of natural killer (NK) cells, but the appearance of a human anti-mouse antibody (HAMA) response prevented its use for prolonged therapy. Here, we describe an effort to humanize the Fab arm directed against FcgammaRIII (CD16),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
